161 related articles for article (PubMed ID: 30196511)
1. Parallel Evolution of Antibody Affinity and Thermal Stability for Optimal Biotherapeutic Development.
Franklin E; Cunningham O; Fennell B
Methods Mol Biol; 2018; 1827():457-477. PubMed ID: 30196511
[TBL] [Abstract][Full Text] [Related]
2. CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous delivery.
Fennell BJ; McDonnell B; Tam AS; Chang L; Steven J; Broadbent ID; Gao H; Kieras E; Alley J; Luxenberg D; Edmonds J; Fitz LJ; Miao W; Whitters MJ; Medley QG; Guo YJ; Darmanin-Sheehan A; Autin B; Shúilleabháin DN; Cummins E; King A; Krebs MR; Grace C; Hickling TP; Boisvert A; Zhong X; McKenna M; Francis C; Olland S; Bloom L; Paulsen J; Somers W; Jensen A; Lin L; Finlay WJ; Cunningham O
MAbs; 2013; 5(6):882-95. PubMed ID: 23995618
[TBL] [Abstract][Full Text] [Related]
3. Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries.
Cembrola B; Ruzza V; Troise F; Esposito ML; Sasso E; Cafaro V; Passariello M; Visconte F; Raia M; Del Vecchio L; D'Alise AM; Cortese R; Scarselli E; Zambrano N; De Lorenzo C; Nicosia A
Biomed Res Int; 2019; 2019():6051870. PubMed ID: 31976323
[TBL] [Abstract][Full Text] [Related]
4. Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.
Lehmann A; Wixted JH; Shapovalov MV; Roder H; Dunbrack RL; Robinson MK
MAbs; 2015; 7(6):1058-71. PubMed ID: 26337947
[TBL] [Abstract][Full Text] [Related]
5. Use of micro-emulsion technology for the directed evolution of antibodies.
Buhr DL; Acca FE; Holland EG; Johnson K; Maksymiuk GM; Vaill A; Kay BK; Weitz DA; Weiner MP; Kiss MM
Methods; 2012 Sep; 58(1):28-33. PubMed ID: 22819852
[TBL] [Abstract][Full Text] [Related]
6. Attainment of 15-fold higher affinity of a Fusarium-specific single-chain antibody by directed molecular evolution coupled to phage display.
Liu JL; Hu ZQ; Xing S; Xue S; Li HP; Zhang JB; Liao YC
Mol Biotechnol; 2012 Oct; 52(2):111-22. PubMed ID: 22161226
[TBL] [Abstract][Full Text] [Related]
7. Antibody Affinity and Stability Maturation by Error-Prone PCR.
Unkauf T; Hust M; Frenzel A
Methods Mol Biol; 2018; 1701():393-407. PubMed ID: 29116518
[TBL] [Abstract][Full Text] [Related]
8. Antibody-Based Protective Immunity against Helminth Infections: Antibody Phage Display Derived Antibodies against BmR1 Antigen.
Rahumatullah A; Abdul Karim IZ; Noordin R; Lim TS
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165352
[TBL] [Abstract][Full Text] [Related]
9. Effective Optimization of Antibody Affinity by Phage Display Integrated with High-Throughput DNA Synthesis and Sequencing Technologies.
Hu D; Hu S; Wan W; Xu M; Du R; Zhao W; Gao X; Liu J; Liu H; Hong J
PLoS One; 2015; 10(6):e0129125. PubMed ID: 26046845
[TBL] [Abstract][Full Text] [Related]
10. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
[TBL] [Abstract][Full Text] [Related]
11. Affinity maturation and fine functional mapping of an antibody fragment against a novel neutralizing epitope on human vascular endothelial growth factor.
Lamdan H; Gavilondo JV; Muñoz Y; Pupo A; Huerta V; Musacchio A; Pérez L; Ayala M; Rojas G; Balint RF; Larrick JW
Mol Biosyst; 2013 Aug; 9(8):2097-106. PubMed ID: 23702826
[TBL] [Abstract][Full Text] [Related]
12. A Novel Human scFv Library with Non-Combinatorial Synthetic CDR Diversity.
Bai X; Kim J; Kang S; Kim W; Shim H
PLoS One; 2015; 10(10):e0141045. PubMed ID: 26484868
[TBL] [Abstract][Full Text] [Related]
13. Selection of affinity-improved neutralizing human scFv against HBV PreS1 from CDR3 VH/VL mutant library.
Chen Y; Bai Y; Guo X; Wang W; Zheng Q; Wang F; Sun D; Li D; Ren G; Yin J
Biologicals; 2016 Jul; 44(4):271-275. PubMed ID: 27255707
[TBL] [Abstract][Full Text] [Related]
14. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei.
Kim HS; Tsai S; Zou N; Lo SC; Wear DJ; Izadjoo MJ
J Immunol Methods; 2011 Feb; 365(1-2):101-9. PubMed ID: 21172353
[TBL] [Abstract][Full Text] [Related]
15. Generation of high-affinity human antibodies by combining donor-derived and synthetic complementarity-determining-region diversity.
Hoet RM; Cohen EH; Kent RB; Rookey K; Schoonbroodt S; Hogan S; Rem L; Frans N; Daukandt M; Pieters H; van Hegelsom R; Neer NC; Nastri HG; Rondon IJ; Leeds JA; Hufton SE; Huang L; Kashin I; Devlin M; Kuang G; Steukers M; Viswanathan M; Nixon AE; Sexton DJ; Hoogenboom HR; Ladner RC
Nat Biotechnol; 2005 Mar; 23(3):344-8. PubMed ID: 15723048
[TBL] [Abstract][Full Text] [Related]
16. Improving antibody binding affinity and specificity for therapeutic development.
Bostrom J; Lee CV; Haber L; Fuh G
Methods Mol Biol; 2009; 525():353-76, xiii. PubMed ID: 19252851
[TBL] [Abstract][Full Text] [Related]
17. Construction of human antibody gene libraries and selection of antibodies by phage display.
Frenzel A; Kügler J; Wilke S; Schirrmann T; Hust M
Methods Mol Biol; 2014; 1060():215-43. PubMed ID: 24037844
[TBL] [Abstract][Full Text] [Related]
18. A strategy for phage display selection of functional domain-exchanged immunoglobulin scaffolds with high affinity for glycan targets.
Stewart A; Liu Y; Lai JR
J Immunol Methods; 2012 Feb; 376(1-2):150-5. PubMed ID: 22233878
[TBL] [Abstract][Full Text] [Related]
19. Array-In-Well Epitope Mapping of Phage-Displayed Antibodies.
Lamminmäki U; Batra G; Saviranta P
Methods Mol Biol; 2018; 1785():129-140. PubMed ID: 29714016
[TBL] [Abstract][Full Text] [Related]
20. Rapid Selection of High-Affinity Antibody scFv Fragments Using Ribosome Display.
Dreier B; Plückthun A
Methods Mol Biol; 2018; 1827():235-268. PubMed ID: 30196501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
